ChartMill assigns a Buy % Consensus number of 84% to PVLA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-05 | Clear Street | Initiate | Buy |
| 2025-12-05 | BTIG | Initiate | Buy |
| 2025-12-04 | Craig-Hallum | Initiate | Buy |
| 2025-11-24 | Stifel | Maintains | Buy -> Buy |
| 2025-11-19 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2025-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-10 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-06 | TD Cowen | Maintains | Buy -> Buy |
| 2025-11-06 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-09 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-02 | Truist Securities | Maintains | Buy -> Buy |
| 2025-09-26 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-09-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-24 | Stifel | Maintains | Buy -> Buy |
| 2025-09-09 | Oppenheimer | Initiate | Outperform |
| 2025-08-19 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-06 | Raymond James | Initiate | Outperform |
| 2025-08-04 | LifeSci Capital | Initiate | Outperform |
| 2025-07-21 | Truist Securities | Initiate | Buy |
| 2025-05-16 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-09 | Chardan Capital | Initiate | Buy |
| 2025-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-26 | Stifel | Initiate | Buy |
| 2025-03-25 | Jones Trading | Initiate | Buy |
18 analysts have analysed PVLA and the average price target is 133.71 USD. This implies a price increase of 35.63% is expected in the next year compared to the current price of 98.58.
The consensus rating for PALVELLA THERAPEUTICS INC (PVLA) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.